Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)

JACC: Cardiovascular Interventions

Volumn 8, Issue 12, 2015, Pages 1614-1622

  Zeller, Thomas ^a   Beschorner, Ulrich ^b   Pilger, Ernst ^c   Bosiers, Marc ^d   Deloose, Koen ^d   Peeters, Patrick ^e   Scheinert, Dierk ^f   Schulte, Karl Ludwig ^g   Rastan, Aljoscha ^a   Brodmann, Marianne ^c  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b coreLab Bad Krozingen GmbH ^*  (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d AZ Sint Blasius   (Belgium)

^e IMELDA HOSPITAL   (Belgium)

^f Park Krankenhaus Leipzig   (Germany)

^g Königin Elisabeth Herzberge Hospital   (Germany)

Author keywords

below the knee; critical limb ischemia; drug coated balloon; drug eluting balloon; infrapopliteal; peripheral artery disease

Indexed keywords

PACLITAXEL; BIOMATERIAL; CARDIOVASCULAR AGENT;

ARTICLE; CLAUDICATION; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DEVICE SAFETY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; INFRAPOPLITEAL ARTERY; LEG AMPUTATION; LEG ARTERY; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PACLITAXEL COATED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; AMPUTATION; CLINICAL TRIAL; COMPARATIVE STUDY; CRITICAL ILLNESS; DEVICES; EQUIPMENT DESIGN; FEMALE; INTERMITTENT CLAUDICATION; ISCHEMIA; LIMB SALVAGE; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDY; RADIOGRAPHY; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; VASCULAR PATENCY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CRITICAL ILLNESS; EQUIPMENT DESIGN; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LIMB SALVAGE; MALE; MIDDLE AGED; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY; YOUNG ADULT;

EID: 84945583724     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.07.011     Document Type: Article

References (21)

1. F.G. Fowkes, D. Rudan, I. Rudan, and et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 2013 1329 1340
2. N. Malyar, T. Fürstenberg, J. Wellmann, and et al. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis Eur Heart J 34 2013 2706 2714
3. J.J. Naoum, and E.J. Arbid Endovascular techniques in limb salvage: infrapopliteal angioplasty Methodist Debakey Cardiovasc J 9 2013 103 107
4. M. Tendera, V. Aboyans, M.L. Bartelink, et al. for the European Stroke Organisation ESC Committee for Practice Guidelines ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2851 2906
5. G. Tepe, T. Zeller, T. Albrecht, and et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
6. G. Tepe, J. Laird, P. Schneider, and et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial Circulation 131 2015 495 502
7. M. Werk, T. Albrecht, D.R. Meyer, and et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 2012 831 840
8. D. Scheinert, K.L. Schulte, T. Zeller, J. Lammer, and G. Tep Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial J Endovasc Ther 22 2015 14 21
9. M. Joner, R.A. Byrne, J.M. Lapointe, and et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis Thromb Haemost 105 2011 864 872
10. R. Toelg, B. Merkely, A. Erglis, and et al. Coronary artery treatment with paclitaxel coated balloon using a BTHC excipient: clinical results of the international real world DELUX Registry EuroIntervention 10 2014 591 599
11. R. Dattilo, S.I. Himmelstein, and R.F. Cuff The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease J Invasive Cardiol 26 2014 355 360
12. T. Zeller, I. Baumgartner, D. Scheinert, et al. for the IN.PACT DEEP Trial Investigators Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial J Am Coll Cardiol 64 2014 1568 1576
13. M.S. Conte, P.J. Geraghty, A.W. Bradbury, and et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1462 1473
14. F. Liistro, I. Porto, P. Angioli, and et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia Circulation 128 2013 615 621
15. A. Schmidt, M. Piorkowski, M. Werner, and et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome J Am Coll Cardiol 58 2011 1105 1109
16. F. Baumann, E. Groechenig, and N. Diehm Does patency matter in patients with critical limb ischemia undergoing endovascular revascularization? Ann Vasc Dis 7 2014 11 16
17. D. Siablis, P.M. Kitrou, S. Spiliopoulos, K. Katsanos, and D. Karnabatidis Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial J Am Coll Cardiol Intv 7 2014 1048 1056
18. F. Fanelli, A. Cannavale, M. Gazzetti, and et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease Cardiovasc Intervent Radiol 37 2014 898 907
19. V.S. Kashyap, M.L. Pavkov, P.D. Bishop, and et al. Angiography underestimates peripheral atherosclerosis: lumenography revisited J Endovasc Ther 15 2008 117 125
20. J.R. Laird, and E.J. Armstrong Drug-coated balloons for infrapopliteal disease: digging deep to understand the impact of a negative trial J Am Coll Cardiol 64 2014 1577 1579
21. T. Zeller, S. Schmitmeier, G. Tepe, and A. Rastan Drug-coated balloons in the lower limb J Cardiovasc Surg (Torino) 52 2011 235 243